company background image
989 logo

Jiuzhitang SZSE:000989 Stock Report

Last Price


Market Cap







13 Jun, 2024


Company Financials

989 Stock Overview

Provides traditional Chinese, chemical, biological, and health medicine products in China.

989 fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance2/6
Financial Health5/6

Jiuzhitang Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Jiuzhitang
Historical stock prices
Current Share PriceCN¥6.83
52 Week HighCN¥14.08
52 Week LowCN¥6.35
1 Month Change-15.37%
3 Month Change-24.61%
1 Year Change-49.85%
3 Year Change-20.58%
5 Year Change-24.45%
Change since IPO-72.72%

Recent News & Updates

Recent updates

Shareholder Returns

989CN PharmaceuticalsCN Market

Return vs Industry: 000989 underperformed the CN Pharmaceuticals industry which returned -9.9% over the past year.

Return vs Market: 000989 underperformed the CN Market which returned -14.4% over the past year.

Price Volatility

Is 989's price volatile compared to industry and market?
989 volatility
989 Average Weekly Movement5.3%
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.1%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 000989's share price has been volatile over the past 3 months.

Volatility Over Time: 000989's weekly volatility (5%) has been stable over the past year.

About the Company

19993,519Xu Xiang

Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. The company offers Shuxuetong injections, Angong Niuhuang pills, Gastrodia Gouteng granules, Danxi granules, and Compound Jiangzhi tablets for cardiovascular and neurological treatment; Nudehua Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Analgesic capsules for the treatment in gynecology; Houyan pills for ear, nose, and throat (ENT) diseases; Jianwei Yuyang tablets for digestion; and prescription drug product systems, Jiaqi Ganxian granules, and Chidan Tuihuang granules for liver diseases. It also provides over the counter (OTC) drugs comprising blood-tonifying, cardiovascular and cerebrovascular, urinary system, pediatric, gynecologic, bone and muscles, respiratory system, dermatologic, nervous system, ENT, and digestive system products; and stem cell and other drugs.

Jiuzhitang Co., Ltd. Fundamentals Summary

How do Jiuzhitang's earnings and revenue compare to its market cap?
989 fundamental statistics
Market capCN¥5.91b
Earnings (TTM)CN¥297.41m
Revenue (TTM)CN¥2.96b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
989 income statement (TTM)
Cost of RevenueCN¥1.18b
Gross ProfitCN¥1.79b
Other ExpensesCN¥1.49b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date


Earnings per share (EPS)0.35
Gross Margin60.31%
Net Profit Margin10.04%
Debt/Equity Ratio2.9%

How did 989 perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.